<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> has been documented in patients with β-<z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It could result in <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> in several organs including brain involvement, which deserves particular attention </plain></SENT>
<SENT sid="2" pm="."><plain>We summarized the prevalence of cerebral involvement in patients with β-<z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> worldwide </plain></SENT>
<SENT sid="3" pm="."><plain>We conducted an electronic search on PUBMED (MEDLINE), SCOPUS, and Google Scholar databases up to January 2011 </plain></SENT>
<SENT sid="4" pm="."><plain>Overall 152 thalassemic patients with cerebral <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> and a proportion of 1.13% (134 of 11770) were recorded </plain></SENT>
<SENT sid="5" pm="."><plain>From <z:hpo ids='HP_0000001'>all</z:hpo> patients with cerebral <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo>, 74 (48%) were splenectomized </plain></SENT>
<SENT sid="6" pm="."><plain>Cerebral <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> were reported after transfusion in six β-<z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e>, and two β-<z:e sem="disease" ids="C0271979" disease_type="Disease or Syndrome" abbrv="">thalassemia intermedia</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>Three β-<z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> patients had irregular transfusion and 22 β-<z:e sem="disease" ids="C0271979" disease_type="Disease or Syndrome" abbrv="">thalassemia intermedia</z:e> patients were not transfused </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0001894'>Thrombocytosis</z:hpo> were determined in 11 β-<z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e>, and 15 β-<z:e sem="disease" ids="C0271979" disease_type="Disease or Syndrome" abbrv="">thalassemia intermedia</z:e> patients </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0001638'>Cardiomyopathy</z:hpo> was present in 13 β-<z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> and four β-<z:e sem="disease" ids="C0271979" disease_type="Disease or Syndrome" abbrv="">thalassemia intermedia</z:e> patients </plain></SENT>
<SENT sid="10" pm="."><plain>Also, nine β-<z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> patients had <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Activated protein C resistant, decreased protein C or protein S or plasminogen level was detected in eight β-<z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> patients </plain></SENT>
<SENT sid="12" pm="."><plain>Cerebral involvement appears to be associated with increasing age, transfusion naivety, splenectomy, <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo>, intensive transfusion, decreased protein C level, and having risk factors for <z:hpo ids='HP_0001297'>cerebrovascular accident</z:hpo> such as <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, and <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="13" pm="."><plain>In light of these findings, diagnostic MRI is recommended in high-risk groups to screen for early asymptomatic brain damage </plain></SENT>
<SENT sid="14" pm="."><plain>If <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> is found, the administration of antiplatelet aggregants or blood transfusion is likely to be beneficial </plain></SENT>
<SENT sid="15" pm="."><plain>In addition, in thalassemic patients who complicated with a thromboembolic event, secondary prophylaxis could be helpful to prevent cerebral <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> </plain></SENT>
</text></document>